We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+30.88%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.73B
AUM Growth
+$507M
Cap. Flow
+$31.1M
Cap. Flow %
1.14%
Top 10 Hldgs %
21.62%
Holding
273
New
30
Increased
132
Reduced
65
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 29.35%
2 Healthcare 21.4%
3 Industrials 18.56%
4 Financials 13.16%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLIC icon
76
Kulicke & Soffa
KLIC
$5.09B
$14.3M 0.52%
412,622
+16,654
+4% +$542K
TREE icon
77
LendingTree
TREE
$645M
$14.2M 0.52%
381,978
+3,415
+0.9% +$138K
LPX icon
78
Louisiana-Pacific
LPX
$5.17B
$14.1M 0.52%
163,629
-73,550
-31% -$6.54M
SOC icon
79
Sable Offshore Corp
SOC
$834M
$13.4M 0.49%
611,613
+320,589
+110% +$7.46M
SKYT icon
80
SkyWater Technology
SKYT
$1.54B
$13.4M 0.49%
1,362,983
+362,267
+36% +$2.92M
ONTO icon
81
Onto Innovation
ONTO
$13.9B
$13.1M 0.48%
+130,150
New +$13.9M
IONQ icon
82
IonQ
IONQ
$13B
$12.9M 0.47%
+301,357
New +$10.1M
ACAD icon
83
Acadia Pharmaceuticals
ACAD
$4.38B
$12.8M 0.47%
592,358
-223,547
-27% -$4.16M
ITGR icon
84
Integer Holdings
ITGR
$3.24B
$12.8M 0.47%
103,824
+97,501
+1,542% +$11.6M
STRL icon
85
Sterling Infrastructure
STRL
$19.6B
$12.7M 0.46%
+54,955
New +$9.59M
WSBC icon
86
WesBanco
WSBC
$3.92B
$12.1M 0.44%
383,527
+14,711
+4% +$445K
AXSM icon
87
Axsome Therapeutics
AXSM
$11.8B
$11.7M 0.43%
+112,469
New +$11.9M
EE icon
88
Excelerate Energy
EE
$1.24B
$11.7M 0.43%
+400,393
New +$11.2M
KALV
89
DELISTED
KalVista Pharmaceuticals
KALV
$11.7M 0.43%
1,038,049
+139,859
+16% +$1.71M
CCOI icon
90
Cogent Communications
CCOI
$549M
$11.7M 0.43%
243,212
+10,940
+5% +$556K
TRIN icon
91
Trinity Capital
TRIN
$1.6B
$11.7M 0.43%
829,710
+30,949
+4% +$447K
FIVE icon
92
Five Below
FIVE
$11.2B
$11.6M 0.43%
88,558
+86,728
+4,739% +$8.45M
RXO icon
93
RXO
RXO
$4.83B
$11.5M 0.42%
731,600
-123,386
-14% -$1.87M
PWP icon
94
Perella Weinberg Partners
PWP
$1.16B
$11M 0.4%
568,206
+164,926
+41% +$2.91M
COGT icon
95
Cogent Biosciences
COGT
$6.68B
$10.4M 0.38%
+1,445,774
New +$8.01M
BOW
96
Bowhead Specialty Holdings
BOW
$1.01B
$9.19M 0.34%
244,864
+9,011
+4% +$345K
MARA icon
97
Marathon Digital Holdings
MARA
$4.08B
$9.09M 0.33%
579,571
+252,864
+77% +$3.62M
BE icon
98
Bloom Energy
BE
$61.1B
$8.99M 0.33%
375,796
+15,382
+4% +$298K
ASIC
99
Ategrity Specialty Insurance
ASIC
$1.09B
$8.61M 0.32%
+400,022
New +$9.15M
SYRE icon
100
Spyre Therapeutics
SYRE
$8.7B
$8.47M 0.31%
565,863
+18,036
+3% +$267K

Similar funds

Emerald Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Emerald Advisers held 273 positions worth $2.73B, up 23% from $2.22B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Emerald Advisers's Q2 2025 filing shows 30 new, 132 increased, 65 reduced and 25 closed positions. Its largest new stake was Mercury Systems: 456,713 shares worth $24.6M. The largest sale was FTAI Aviation, an estimated $52.2M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Emerald Advisers's largest Q2 2025 buy was Mercury Systems: 456,713 shares worth $24.6M.
  • Emerald Advisers added most to Clearwater Analytics in Q2 2025, an estimated $13.2M increase.
  • Emerald Advisers's biggest Q2 2025 reduction was FTAI Aviation, cutting an estimated $52.2M.
  • Emerald Advisers fully exited Blueprint Medicines in Q2 2025, selling an estimated $35.5M.
  • Emerald Advisers's ten largest holdings make up 22% of its $2.73B portfolio in Q2 2025.
  • Emerald Advisers opened 30 new positions and closed 25 in Q2 2025.
  • Emerald Advisers's portfolio value rose 23% quarter-over-quarter to $2.73B.

Based on Emerald Advisers's 13F filing for Q2 2025, filed 4 Aug 2025.